MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer (L37897) - R4 - Effective October 14, 2021

Date Posted: October 9, 2025

This MolDX Local Coverage Determination (LCD) has been revised under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Effective Date: October 14, 2021

Summary of Changes:

Under Issue Description: Formatting, punctuation, and typographical errors were corrected. Under Coverage Indications, Limitations and/or Medical Necessity: Formatting, punctuation, and typographical errors were corrected.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCD or access it via the CMS Medicare Coverage Database (MCD).

Last Updated Oct 09 , 2025